[1]高 磊 综述 陈 磊 审校.凝血酶在中枢神经系统疾病中的作用[J].中国临床神经外科杂志,2019,(08):507-510.[doi:10.13798/j.issn.1009-153X.2019.08.021]
点击复制

凝血酶在中枢神经系统疾病中的作用()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2019年08期
页码:
507-510
栏目:
论著
出版日期:
2019-08-25

文章信息/Info

文章编号:
1009-153X(2019)08-0507-04
作者:
高 磊 综述 陈 磊 审校
510000 广州,南方医科大学南方医院神经外科(高 磊、陈 磊)
关键词:
中枢神经系统疾病凝血酶凝血酶受体凝血酶抑制剂
分类号:
R 651
DOI:
10.13798/j.issn.1009-153X.2019.08.021
文献标志码:
A

参考文献/References:

[1] Deschepper CF, Bigornia V, Berens ME, et al. Production of thrombin and antithrombin Ⅲ by brain and astroglial cell cultures [J]. Brain Res Mol Brain Res, 1991, 11: 355-358. [2] Dihanich M, Kaser M, Reinhard E, et al. Prothrombin mRNA is expressed by cells of the nervous system [J]. Neuron, 1991, 6(4): 575-581. [3] Jamison CS, Degen SJ. Prenatal and postnatal expression of mRNA coding for rat prothrombin [J]. Biochim Biophys Acta, 1991, 1088(2): 208-216. [4] Yamada T, Nagai Y. Immunohistochemical studies of human tissues with antibody to factor Xa [J]. Histochem J, 1996, 28 (1): 73-77. [5] Shikamoto Y, Morita T. Expression of factor X in both the rat brain and cells of the central nervous system [J]. FEBS Lett, 1999, 463(3): 387-389. [6] Hua Y, Xi G, Keep RF, et al. Plasminogen activator inhibi- tor-1 induction after experimental intracerebral hemorrhage [J]. J Cereb Blood Flow Metab, 2002, 22(1): 55-61. [8] 贾文志. 脑出血大鼠血肿周围脑组织 PN-1、thrombin、 PAR-1的表达变化及其相关性[J]. 山东医药,2016,56 (29):36-38. [9] Striggow F, Riek-Burchardt M, Kiesel A, et al. Four diffe- rent types of protease-activated receptors are widely expre- ssed in the brain and are up-regulated in hippocampus by severe ischemia [J]. Eur J Neurosci, 2001, 14(4): 595-608. [10] Weinstein JR, Gold SJ, Cunningham DD, et al. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA [J]. J Neurosci, 1995, 15(4): 2906-2919. [11] Jamison C S, Degen S J. Prenatal and postnatal expression of mRNA coding for rat prothrombin [J]. Biochim Biophys Acta, 1991, 1088(2): 208-216. [12] Lyden P, Pereira B, Chen B, et al. Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models [J]. Stroke, 2014, 45(3): 896-899. [13] Kameda K, Kikkawa Y, Hirano M, et al. Combined argatro- ban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarach- noid haemorrhage [J]. Br J Pharmacol, 2012, 165: 106-119. [14] Akiyama H, Ikeda K, Kondo H, et al. Thrombin accumula- tion in brains of patients with Alzheimer’s disease [J]. Neurosci Lett, 1992, 146(2): 152-154. [15] Lee DY, Park KW, Jin BK. Thrombin induces neurodegene- ration and microglial activation in the cortex in vivo and in vitro: proteolytic and non-proteolytic actions [J]. Biochem Biophys Res Commun, 2006, 346(3): 727-738. [16] Lee K R, Drury I, Vitarbo E, et al. Seizures induced by in- tracerebral injection of thrombin: a model of intracerebral hemorrhage [J]. J Neurosurg, 1997, 87(1): 73-78. [17] Gingrich M B, Junge C E, Lyuboslavsky P, et al. Potentiation of NMDA receptor function by the serine protease thrombin [J]. J Neurosci, 2000, 20(12): 4582-4595. [18] Rao H V, Thirumangalakudi L, Desmond P, et al. Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons [J]. J Neurochem, 2007, 101(2): 498-505. [19] Fujimoto S, Katsuki H, Kume T, et al. Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organo- typic slice cultures [J]. Neurobiol Dis, 2006, 22: 130-142. [20] Karabiyikoglu M, Hua Y, Keep RF, et al. Intracerebral hiru- din injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow [J]. J Cereb Blood Flow Metab, 2004, 24(2): 159-166. [21] Wu X, Zhang W, Li JY, et al. Induction of apoptosis by thrombin in the cultured neurons of dorsal motor nucleus of the vagus [J]. Neurogastroenterol Motil, 2011, 23(3): 279- 285, e123-e124. [22] Mirante O, Price M, Puentes W, et al. Endogenous protease nexin-1 protects against cerebral ischemia [J]. Int J Mol Sci, 2013, 14(8): 16719-16731. [23] 郑秋月,陈应柱. 凝血酶在脑出血后白质损伤中的作用及 其机制[J]. 国际脑血管病杂志, 2017, 25(5): 449-453. [24] Striggow F, Riek M, Breder J, et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degene- ration at high concentrations [J]. Proc Natl AcadSci U S A, 2000, 97(5): 2264-2269. [25] Xi G, Keep RF, Hua Y, et al. Attenuation of thrombin- induced brain edema by cerebral thrombin preconditioning [J]. Stroke, 1999, 30(6): 1247-1255. [26] Henrich-Noack P, Striggow F, Reiser G, et al. Precondition- ing with thrombin can be protective or worsen damage after endothelin-1-induced focal ischemia in rats [J]. J Neurosci Res, 2006, 83(3): 469-475. [27] Wang H, Reiser G. Thrombin signaling in the brain: the role of protease-activated receptors [J]. Biol Chem, 2003, 384(2): 193-202. [28] Macfarlane SR, Seatter MJ, Kanke T, et al. Proteinase-acti- vated receptors [J]. Pharmacol Rev, 2001, 53(2): 245-282. [29] Nakamura T, Keep RF, Hua Y, et al. Intracerebral hemor- rhage induces edema and oxidative stress and alters N- methyl-D-aspartate receptor subunits expression [J]. Acta Neurochir Suppl, 2005, 95: 421-424. [30] Granziera C, Thevenet J, Price M, et al. Thrombin-induced ischemic tolerance is prevented by inhibiting c-jun N- terminal kinase [J]. Brain Res, 2007, 1148: 217-225.

相似文献/References:

[1]田 其 综述 李明昌 审校.外泌体微小RNA在中枢神经系统疾病诊断中作用的研究进展[J].中国临床神经外科杂志,2019,(09):570.[doi:10.13798/j.issn.1009-153X.2019.09.022]

备注/Memo

备注/Memo:
(2018-07-11收稿,2018-12-10修回)
更新日期/Last Update: 2019-08-25